Integrum aktie (INTEG B) | Pressmeddelande - Börskollen
Börskollen - Aktier, fonder och ekonominyheter

Börskollen

För dig med koll på börsen

•Trendskifte: Banken nu först ut med att höja rörliga boräntan – så påverkas du

Pressmeddelanden från Integrum

 Bevaka pressreleaser
Kurs från TradingView
StartNyheterPressreleaserRiktkurserInsynshandelBlankningAnalyserBloggarVideosPodcasts

Ett strategiskifte för att accelerera kommersialiseringen av implantatsystemet OPRA®

Tredje kvartalet 2024/25 (november–januari) · Nettoomsättningen uppgick till 23,7 (30,1) MSEK · Rörelseresultatet uppgick till -7,4 (0,...

Cision • 03 Mar 07:00

A strategic shift to accelerate the commercialization of OPRA® Implant System

Third quarter 2024/25 (November – January) · Net sales amount to 23.

Cision • 03 Mar 07:00

Integrum AB: Invitation to the Third Quarter 2024/25 Results Presentation

Mölndal, Sweden – February 27, 2025 — Integrum (publ) (Nasdaq First North Growth Market: INTEG B) will host a webcast presentation of its th...

Cision • 28 Feb 10:07

Integrum AB: Inbjudan till presentation av Integrums tredje kvartal 2024/25

Mölndal, Sweden – 27 februari, 2025 — Integrum (publ) (Nasdaq First North Growth Market: INTEG B) kommer att hålla en webcastpresentation av...

Cision • 28 Feb 10:07

Integrum har genomfört en riktad nyemission om 1 937 500 B-aktier och tillförs cirka 31 miljoner kronor

Mölndal, Sverige – 18 februari 2025 – Styrelsen i Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) (“Integrum” eller “Bolaget”...

Cision • 18 Feb 22:00

Integrum has carried out a directed new issue of 1,937,500 series B shares, raising proceeds of approximately SEK 31 million

Mölndal, Sweden – 18 February 2025 – The Board of Directors of Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) (“Integrum” or...

Cision • 18 Feb 22:00

Integrum explores the conditions to carry out a directed new issue of series B shares of approximately SEK 30 million

Mölndal, Sweden – 18 February 2025 – The Board of Directors of Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) (“Integrum” or...

Cision • 18 Feb 17:39

Integrum utreder förutsättningarna för att genomföra en riktad nyemission av B-aktier om cirka 30 miljoner kronor

Mölndal, Sverige – 18 februari 2025 – Styrelsen i Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) (“Integrum” eller “Bolaget”...

Cision • 18 Feb 17:39

Integrum publishes preliminary revenue, result and cash flow figures for Q3, 2024/2025

Mölndal, Sweden – February 18, 2025 —Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) today publishes its preliminary revenue,...

Cision • 18 Feb 17:32

Integrum publicerar preliminär omsättning, resultat och kassaflöde för Q3 2024/2025

Mölndal, – 18 februari 2025 — Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) publicerar idag preliminära uppgifter om omsätt...

Cision • 18 Feb 17:32

Integrum implements strategic shift to accelerate the commercialization of OPRA® Implant System and generate cost efficiencies up to SEK 20 million annually

Mölndal, Sweden – February 18, 2025 - Integrum (publ) (Nasdaq First North Growth Market: INTEG B) today announces a strategic shift to accel...

Cision • 18 Feb 17:31

Integrum genomför strategiskifte för att accelerera kommersialiseringen av OPRA® Implant System och uppnå kostnadseffektiviseringar på upp till 20 miljoner kronor årligen

Mölndal – 18 februari, 2025 - Integrum (publ) (Nasdaq First North Growth Market: INTEG B) presenterar idag ett strategiskifte för att accele...

Cision • 18 Feb 17:31

Integrum Partners with SPS to Expand 2025 Education Calendar, Enhancing Learning Opportunities

Integrum, ticker INTEG, the leader in innovative bone-anchored prosthetic solutions, is proud to announce the expansion of their 2025 Educat...

Cision • 28 Jan 09:48

Integrum samarbetar med SPS för att bredda utbildningskalendern 2025 och förbättrar möjligheter till lärande

Integrum, kortnamn INTEG, det medicintekniska bolaget som tillhandahåller benförankrade OPRA® Implant System till amputerade, är stolta över...

Cision • 28 Jan 09:48

Integrum välkomnar nya styrelseledamöter

Integrum AB (publ), kortnamn INTEG, det medicintekniska bolaget som tillhandahåller det benförankrade OPRA™ Implantat Systemet till amputera...

Cision • 21 Jan 21:31

Integrum welcomes new board members

Integrum AB (publ), ticker INTEG, the medical technology company that provides the bone-anchored OPRA implant system to amputees, welcomes t...

Cision • 21 Jan 21:19

Stämmokommuniké – Integrum AB

Integrum AB har den 20 januari 2025 hållit extra bolagsstämma.

Cision • 20 Jan 16:01

Integrum partners with Intelerad to Streamline Surgical Planning and Enhance Patient Outcomes in the US

Integrum AB (publ), ticker INTEG, the medical technology company that provides the bone-anchored OPRA® Implant System to amputees, partners ...

Cision • 15 Jan 14:00

Kallelse till extra bolagsstämma i Integrum AB

Aktieägarna i Integrum AB, org. nr 556407-3145 ("Bolaget"), kallas härmed till extra bolagsstämma den 20 januari 2025, kl.

Cision • 18 Dec 2024 22:14

The nomination committee in Integrum plans to propose the election of Anette Lindqvist as board member at an extraordinary general meeting

Integrum AB (publ), short name INTEG, the medical technology company that provides the bone-anchored OPRA™ Implant System to amputees, annou...

Cision • 18 Dec 2024 15:07

Valberedningen i Integrum planerar att föreslå nyval av Anette Lindqvist som styrelseledamot på extra stämma

Integrum AB (publ), kortnamn INTEG, det medicintekniska bolaget som tillhandahåller det benförankrade OPRA™ Implantat Systemet till amputera...

Cision • 18 Dec 2024 15:07

Ökat kommersiellt fokus leder till återhämtning av Steg 1 operationer i USA

Andra kvartalet 2024/25 (augusti – oktober) · Nettoomsättningen uppgick till 21,8 (27,6) MSEK, vilket är en minskning med 21,0 % jämfört ...

Cision • 04 Dec 2024 07:00

Enhanced Commercial Focus Leads to Rebound in Stage One Surgeries in the US

Second quarter 2024/25 (August – October) · Net sales amount to 21.

Cision • 04 Dec 2024 07:00

Integrum AB: Invitation to the Second Quarter 2024/25 Results Presentation

Mölndal, Sweden – November 29, 2024 — Integrum (publ) (Nasdaq First North Growth Market: INTEG B) will host a webcast presentation of its se...

Cision • 29 Nov 2024 19:38

Integrum Launches Service Initiative to Strengthen U.S. Market Growth

Integrum AB (publ), ticker INTEG, a leader in medical technology and developer of the bone-anchored OPRA® Implant System, announces the laun...

Cision • 28 Nov 2024 10:59

Osseointegration for Amputees Makes its Education Forum Debut at OTA 2024

Integrum AB (publ), ticker INTEG, the medical technology company that provides the bone-anchored OPRA® Implant System to amputees announces ...

Cision • 31 Oct 2024 18:53

Ty Hanners appointed Director of Sales, US, focused on OPRA Implant System for Amputees

Integrum AB (publ), ticker INTEG, the medical technology company that provides the bone-anchored OPRA implant system to amputees, announces ...

Cision • 07 Oct 2024 15:02

Ty Hanners utsedd till försäljningschef i USA med fokus på OPRA-implantatsystem för amputerade

Integrum AB (publ), ticker INTEG, det medicintekniska bolaget som tillhandahåller det benförankrade OPRA-implantatsystemet till amputerade, ...

Cision • 07 Oct 2024 15:02

Årsstämmokommuniké – Integrum AB

Integrum AB har den 25 september 2024 hållit årsstämma.

Cision • 25 Sep 2024 17:47

Välkommen till investerarinformation online med vår nya tillförordnade VD Scott Flora

Integrum AB (publ), det medicintekniska företaget som förbättrar livet för amputerade, bjuder in till ett informationsmöte för investerare o...

Cision • 20 Sep 2024 15:44

Join Us for an Investor Update Online with our Acting CEO Scott Flora

Integrum AB (publ), the medical technology company that improves the lives of amputees, cordially invites you to an online investor informat...

Cision • 20 Sep 2024 15:44

Inger Rydin utses till interim COO och tillträder omedelbart

Integrum AB (publ), det medicintekniska bolaget som förbättrar livet för amputerade, meddelar att Inger Rydin utses till interim COO och ans...

Cision • 17 Sep 2024 17:55

Inger Rydin is appointed interim COO and takes office immediately

Integrum AB (publ), the medical technology company that improves the lives of amputees, announces that Inger Rydin has been appointed interi...

Cision • 17 Sep 2024 17:55

Styrelsen i Integrum utser Scott Flora till tillförordnad VD

Integrums VD Rickard Brånemark har idag tillsammans med styrelsen kommit överens om att han lämnar VD-rollen.

Cision • 15 Sep 2024 22:28

The board of Integrum appoints Scott Flora as acting CEO

Integrums CEO Rickard Brånemark has today agreed together with the board that he will leave the CEO role.

Cision • 15 Sep 2024 22:28

Integrum publicerar årsredovisning 2023/24

Integrum har idag publicerat Årsredovisning 2023/24 för räkenskapsåret 1 maj 2023 till 30 april 2024.

Cision • 04 Sep 2024 16:59

Fokus på långsiktig tillväxt leder till minskad omsättning

FÖRSTA KVARTALET 2024/25 (MAJ – JULI) · Nettoomsättningen uppgick till 18,5 (20,4) MSEK, vilket är en minskning med 9,5 % jämfört med mot...

Cision • 29 Aug 2024 07:00

Focus on long-term growth creates setback in sales

FIRST QUARTER 2024/25 (MAY – JULY) · Net sales amounted to 18.

Cision • 29 Aug 2024 07:00

Kallelse till årsstämma i Integrum AB

Aktieägarna i Integrum AB, org. nr 556407-3145 ("Bolaget"), kallas härmed till årsstämma den 25 september 2024, kl.

Cision • 27 Aug 2024 16:58

Integrum AB: Invitation to the First Quarter 2024/25 Results Presentation

Mölndal, Sweden – August 26, 2024 — Integrum (publ) (Nasdaq First North Growth Market: INTEG B) will host a webcast presentation of its firs...

Cision • 26 Aug 2024 10:25

Integrum has carried out a directed new issue of 961,539 series B shares, raising proceeds of approximately SEK 50 million

Mölndal, Sweden – 13 June 2024 – Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) (“Integrum” or the “Company”) has successful...

Cision • 13 Jun 2024 22:25

Integrum har genomfört en riktad nyemission om 961 539 B-aktier och tillförs cirka 50 miljoner kronor

Mölndal, Sverige – 13 juni 2024 – Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) (“Integrum” eller “Bolaget”) har framgångsr...

Cision • 13 Jun 2024 22:25

Integrum intends to carry out a directed new issue of series B shares of approximately SEK 50 million

Mölndal, Sweden – 13 June 2024 – Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) (“Integrum” or the “Company”) announces its ...

Cision • 13 Jun 2024 17:31

Integrum avser att genomföra en riktad nyemission av B-aktier om cirka 50 miljoner kronor

Mölndal, Sverige – 13 juni 2024 – Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) (“Integrum” eller “Bolaget”) offentliggör a...

Cision • 13 Jun 2024 17:31

Integrum signs Memorandum of Understanding with Coapt for the use of its pattern recognition technology with the e-OPRA[TM] Implant System

Mölndal, Sweden – June 13, 2024 — Integrum (publ) (Nasdaq First North Growth Market: INTEG B) announces that the company has entered a Memor...

Cision • 13 Jun 2024 08:36

Integrum enters collaboration and distribution agreement with Hanger – the leading provider of amputee care and prosthetics in the US

Mölndal, Sweden – June 10, 2024 — Integrum (publ) (Nasdaq First North Growth Market: INTEG B) today announces that the company has entered a...

Cision • 10 Jun 2024 17:16

A Record Year in Sales

FOURTH QUARTER 2023/24 (FEBRUARY – APRIL) · Net sales amount to 26.

Cision • 30 May 2024 07:00

Ett år med rekordomsättning

FJÄRDE KVARTALET 2023/24 (FEBRUARI – APRIL) · Nettoomsättningen uppgick till 26,1 (18,1) MSEK, vilket är en ökning med 43,7 % jämfört med...

Cision • 30 May 2024 07:00

Integrum receives market approval for OPRA[® in Israel]

Mölndal, Sweden – May 29, 2024 - Integrum (publ) (Nasdaq First North Growth Market: INTEG B) announces that the company has received market ...

Cision • 29 May 2024 16:21

Integrum AB: Invitation to the Fourth Quarter 2023/24 Results Presentation

Mölndal, Sweden – May 24, 2024 — Integrum (publ) (Nasdaq First North Growth Market: INTEG B) will host a webcast presentation of its fourth ...

Cision • 24 May 2024 17:06

Integrum has been granted a registered trademark for OPRA® Implant System in the EU

Mölndal, Sweden – May 15, 2024 — Integrum (publ) (Nasdaq First North Growth Marketing: INTEG B) announces that the European Union Intellectu...

Cision • 15 May 2024 07:00

Integrum launches short video documentary to showcase the company’s efforts to treat combat amputees in Ukraine

Mölndal, Sweden – May 3, 2024 — Integrum (publ) (Nasdaq First North Growth Market: INTEG B) announces today that the company has launched a ...

Cision • 03 May 2024 07:39

Integrum expands its product offering to the United Kingdom market

Mölndal, Sweden – May 2, 2024 — Integrum (publ) (Nasdaq First North Growth Market: INTEG B) announces that the company has entered a commerc...

Cision • 02 May 2024 07:00

Integrum kommenterar nedstängningen av Center for Bionics and Pain Research

Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) kommenterar idag att Chalmers tekniska högskola, Göteborgs universitet och Sa...

Cision • 25 Apr 2024 17:17

Integrum expands its product offering into the Israeli market

Mölndal, Sweden – March 26, 2024 — Integrum (publ) (Nasdaq First North Growth Market: INTEG B) announces that the company has entered a comm...

Cision • 26 Mar 2024 07:00

Health economic study shows positive outcome using Integrum’s OPRA[TM] Implant System over socket prostheses in transfemoral amputees

Mölndal, Sweden – March 19, 2024 — Integrum (publ) (Nasdaq First North Growth Market: INTEG B) announces that a team of independent research...

Cision • 19 Mar 2024 07:00

Integrums valberedning utsedd inför årsstämman 2024

Mölndal, 18 mars 2024 – Integrum (publ) (Nasdaq First North Growth Market: INTEG B) meddelar idag att valberedningens ledamöter har utsetts ...

Cision • 18 Mar 2024 16:06

Rättelse Ett nytt kvartal med rekordintäkter och 61 % tillväxt

Siffran för Nyttjanderätter (6 620 KSEK) saknades i den förra versionen och är nu tillagd.

Cision • 29 Feb 2024 09:39

CORRECTION A new record revenue quarter with 61% growth

The figures for Rights of Use assets (6,620 KSEK) were missing in the previous report and have now been added.

Cision • 29 Feb 2024 09:39

Ett nytt kvartal med rekordintäkter och 61 % tillväxt

TREDJE KVARTALET 2023/24 (NOV – JAN) · Nettoomsättningen uppgick till 30,1 (18,7) MSEK, vilket är en ökning med 61 % jämfört med motsvara...

Cision • 29 Feb 2024 07:00

A new record revenue quarter with 61% growth

THIRD QUARTER 2023/24 (NOV – JAN) · Net sales amounts to 30.

Cision • 29 Feb 2024 07:00

Integrum AB: Invitation to the Third Quarter 2023/24 Results Presentation

Mölndal, Sweden – February 23, 2024 — Integrum (publ) (Nasdaq First North Growth Market: INTEG B) will host a webcast presentation of its th...

Cision • 23 Feb 2024 09:26

Integrum has sold and delivered OPRA[TM] Implant Systems to a value of SEK 3.5 million to Center of Excellence in Ukraine

Mölndal, Sweden – January 31, 2024 — Integrum (publ) (Nasdaq First North Growth Market: INTEG B) announces that the company today has sold a...

Cision • 31 Jan 2024 23:31

Integrum establishes Center of Excellence in Ukraine

Mölndal, Sweden – December 20, 2023 — Integrum (publ) (Nasdaq First North Growth Market: INTEG B) today announces that the company has estab...

Cision • 20 Dec 2023 08:41

Integrum’s MDR certification is completed for the OPRA[TM] Implant System

Mölndal, Sweden – December 15, 2023 — Integrum (publ) (Nasdaq First North Growth Market: INTEG B) today announces that the company has recei...

Cision • 15 Dec 2023 09:05

Record sales and profitability

SECOND QUARTER 2023/24 (MAY – JULY) · Net sales amounted to SEK 27.

Cision • 04 Dec 2023 08:30

Rekordförsäljning och lönsamhet

ANDRA KVARTALET 2023/24 (AUG–OKT) · Nettoomsättningen uppgick till 27,6 (20,2) MSEK, vilket är en ökning med 36 % jämfört med motsvarande...

Cision • 04 Dec 2023 08:30

Integrum AB changes Certified Adviser to Carnegie Investment Bank AB (publ)

Mölndal, Sweden – November 30, 2023 — Integrum (publ) (Nasdaq First North Growth Market: INTEG B) today announces a change of Certified Advi...

Cision • 30 Nov 2023 09:46

Integrum AB: Invitation to the Second Quarter 2023/24 Results Presentation

Mölndal, Sweden – November 28, 2023 — Integrum (publ) (Nasdaq First North Growth Market: INTEG B) will host a webcast presentation of its se...

Cision • 28 Nov 2023 11:45

Integrum plans to submit a PMA application to the FDA for the use of OPRA in transhumeral amputations based on existing clinical data

Mölndal, Sweden – November 13, 2023 — Integrum (publ) (Nasdaq First North Growth Market: INTEG B) today announces that the company has held ...

Cision • 13 Nov 2023 08:59

Correction missing MAR reference: Integrum publishes preliminary revenue, result and and cash flow figures for Q2, 2023

Mölndal, Sweden – November 10, 2023 — For technical and administrative reasons, the previous press release was missing the appropriate MAR r...

Cision • 10 Nov 2023 16:50

Clinical study of Integrum’s OPRA™ Implant System on below-knee amputations will include up to 30 patients and is fully funded by the Department of Defense

Mölndal, Sweden – November 10, 2023 — Integrum (publ) (Nasdaq First North Growth Market: INTEG B) today announces that the US Department of ...

Cision • 10 Nov 2023 08:30

Integrum publishes preliminary revenue, result and and cash flow figures for Q2, 2023

Mölndal, Sweden – November 9, 2023 — Integrum (publ) (Nasdaq First North Growth Market: INTEG B) today announces that it expects its revenue...

Cision • 09 Nov 2023 09:05

Integrum’s OPRA™ Implant System gets FDA approval for clinical study on below-knee amputations

Mölndal, Sweden – October 30, 2023 — Integrum (publ) (Nasdaq First North Growth Market: INTEG B) today announces that the company’s OPRA™ Im...

Cision • 30 Oct 2023 08:32

Integrum moves into Turkey

Mölndal, Sweden – October 27, 2023 — Integrum (publ) (Nasdaq First North Growth Market: INTEG B) today announces that the company is enterin...

Cision • 27 Oct 2023 13:46

Integrum announces the world’s first long-term integrated bionic hand enriched with motor and sensory AI

Mölndal, Sweden, October 12, 2023 – Integrum (publ) (Nasdaq First North Growth Market: INTEG B) today announces that the long-term follow-up...

Cision • 12 Oct 2023 08:37

Integrum receives a Unitary Patent for Neuromotus in the EU

Mölndal, Sweden, October 10, 2023 – Integrum (publ) (Nasdaq First North Growth Market: INTEG B) today announces that the company has receive...

Cision • 10 Oct 2023 09:23

Integrum welcomes Scott Flora as full board member

Mölndal, Sweden – October 10, 2023 — Integrum (publ) (Nasdaq First North Growth Market: INTEG B) today announces that Scott Flora was recent...

Cision • 10 Oct 2023 08:44

Årsstämmokommuniké – Integrum AB

Mölndal, Sweden, September 27, 2023 – Integrum (publ) (Nasdaq First North Growth Market: INTEG B) har den 27 september 2023 hållit årsstämma...

Cision • 27 Sep 2023 17:40

Integrum attends international expert workshop on osseointegration and bionic limb reconstruction

Mölndal, Sweden, September 27, 2023 – Integrum (publ) (Nasdaq First North Growth Market: INTEG B) announces today that the company is attend...

Cision • 27 Sep 2023 10:13

Integrum participates in war-related amputee care workshop to support amputee care in Ukraine

Mölndal, Sweden, September 19, 2023 – Integrum (publ) (Nasdaq First North Growth Market: INTEG B) announces today that the company’s CEO Ric...

Cision • 19 Sep 2023 09:01

Integrum initiates a strategic review process to accelerate growth

Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) today announces that its Board of Directors has initiated a review and evalua...

Cision • 14 Sep 2023 08:30

Integrum announces organizational changes and appoints Alex Winber as VP Sales and Marketing in the US

Mölndal, Sweden, September 11, 2023 – Integrum (publ) (Nasdaq First North Growth Market: INTEG B) announces today that the company has appoi...

Cision • 11 Sep 2023 08:30

Integrum receives reimbursement code for Axor II™

Mölndal, Sweden, September 08, 2023 – Integrum (publ) (Nasdaq First North Growth Market: INTEG B) today announces that The Centers for Medic...

Cision • 08 Sep 2023 08:30

Integrum publicerar årsredovisning 2022/23

Integrum publicerar årsredovisning 2022/23

Cision • 06 Sep 2023 23:03

Integrum reports highest quarterly sales revenue ever

FIRST QUARTER 2023/24 (MAY – JULY) · Net sales amounted to SEK 20.

Cision • 31 Aug 2023 08:00

Integrum rapporterar högsta kvartalsintäkterna någonsin

FÖRSTA KVARTALET 2023/24 (MAJ – JULI) · Nettoomsättningen uppgick till 20,4 (17,2) MSEK, vilket är en ökning med 18% jämfört med motsvara...

Cision • 31 Aug 2023 08:00

Kallelse till årsstämma i Integrum AB

Aktieägarna i Integrum AB, org. nr 556407-3145 ("Bolaget"), kallas härmed till årsstämma den 27 september 2023, kl.

Cision • 29 Aug 2023 10:06

Integrum’s technology using AI gives an above-elbow amputee unprecedented control of every finger in a bionic hand

Mölndal, Sweden, July 13, 2023 – Integrum (publ) (Nasdaq First North Growth Market: INTEG B) today announces that the first case study of a ...

Cision • 13 Jul 2023 08:00

Integrum har informerats om att Nämnden för prövning av oredlighet i forskning har friat Rickard Brånemark

Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) meddelar idag att bolaget blivit informerat om att Nämnden för prövning av or...

Cision • 22 Jun 2023 14:14

Integrum appoints Jeffrey S. Zanni as President, U.S.

Mölndal, Sweden, June 16, 2023 – Integrum (publ) (Nasdaq First North Growth Market: INTEG B) today announces that the company has appointed ...

Cision • 16 Jun 2023 18:00

Year End Report May 2022 – April 2023: CONTINUING TO BUILD THE COMPANY

Year End Report May 2022 – April 2023: CONTINUING TO BUILD THE COMPANY

Cision • 08 Jun 2023 08:30

Bokslutskommuniké maj 2022 – april 2023: FORTSATT BOLAGSUTVECKLING

Bokslutskommuniké maj 2022 – april 2023: FORTSATT BOLAGSUTVECKLING

Cision • 08 Jun 2023 08:30

Shirley Ryan AbilityLab receives a USD 8.7 million NIH grant to fund clinical trials including Integrum’s e-OPRA Implant System

Mölndal, Sweden, June 8, 2023 – Integrum (publ) (Nasdaq First North Growth Market: INTEG B) today announced that Shirley Ryan AbilityLab – a...

Cision • 08 Jun 2023 08:00

Integrum invites to Open House Event to celebrate its 25-year anniversary

Mölndal, Sweden – June 1, 2023 — Integrum (publ) (Nasdaq First North Growth Market: INTEG B) will host an Open House Event on June 15 to ina...

Cision • 01 Jun 2023 14:08

Integrum and collaboration partners receive SEK 3.2 million in research grant for textile-based HOPE project

Mölndal, Sweden, June 1, 2023 – Integrum (publ) (Nasdaq First North Growth Market: INTEG B) today announced that the Knowledge Foundation (S...

Cision • 01 Jun 2023 07:45

Integrum appoints Supply Chain Manager

Mölndal, Sweden – May 29, 2023 — Integrum (publ) (Nasdaq First North Growth Market: INTEG B) today announces that the company has appointed ...

Cision • 29 May 2023 14:43

Integrum announces the appointment of Scott Flora as adjunct board membe

Mölndal, Sweden – May 11, 2023 — Integrum (publ) (Nasdaq First North Growth Market: INTEG B) today announces that Scott Flora has been appoi...

Cision • 11 May 2023 13:52

Integrum's CEO Rickard Brånemark holds the keynote lecture at ISPO 2023 in Germany

Mölndal, Sweden, May 09, 2023 - Integrum (publ) (Nasdaq First North Growth Market: INTEG B) today announced that the company's CEO Rickard B...

Cision • 09 May 2023 16:00

Integrum moves into new head office at GoCo Health Innovation Cit

Mölndal, Sweden – May 3, 2023 — Integrum (publ) (Nasdaq First North Growth Market: INTEG B) today announces that the company has moved into ...

Cision • 03 May 2023 08:33